Sarawar S R, Blackman M A, Doherty P C
Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee.
J Infect Dis. 1994 Nov;170(5):1189-94. doi: 10.1093/infdis/170.5.1189.
Subclinical lymphocytic choriomeningitis virus infection primes mice expressing a V beta 8.1D beta 2J beta 2.3C beta 2 T cell receptor as a transgene for induction of fatal hematogenous shock after administration of a dose of staphylococcal enterotoxin B (SEB) that is tolerated by uninfected controls. The lethal effect is greatly diminished by prior depletion of the virus-primed CD4+ T cells. Evidence of transient tumor necrosis factor (TNF) secretion is detected in serum within 1 h of SEB administration, and massive amounts of interferon-gamma (IFN-gamma) and interleukin-6 (IL-6) are present within 4-6 h. Mice are partly protected by treatment with dimeric soluble TNF receptor-Fc fusion protein or the nitric oxide synthase inhibitor, aminoguanidine, neither of which blocks SEB-induced IFN-gamma or IL-6 production. Administration of a monoclonal antibody to IFN-gamma concomitant with SEB effectively neutralizes this cytokine but has no effect on survival.
亚临床淋巴细胞性脉络丛脑膜炎病毒感染使作为转基因表达Vβ8.1Dβ2Jβ2.3Cβ2T细胞受体的小鼠在给予未感染对照可耐受剂量的葡萄球菌肠毒素B(SEB)后引发致命的血源性休克。通过预先清除病毒致敏的CD4 + T细胞,致死效应可大大降低。在给予SEB后1小时内血清中检测到短暂肿瘤坏死因子(TNF)分泌的证据,并且在4 - 6小时内存在大量干扰素-γ(IFN-γ)和白细胞介素-6(IL-6)。用二聚体可溶性TNF受体-Fc融合蛋白或一氧化氮合酶抑制剂氨基胍治疗可部分保护小鼠,这两种药物均不阻断SEB诱导的IFN-γ或IL-6产生。与SEB同时给予抗IFN-γ单克隆抗体可有效中和这种细胞因子,但对生存没有影响。